# FDA Inspection 1300468 - Safrel Pharmaceuticals LLC - January 30, 2026

Source: https://www.keypedia.com/records/fda_inspections/safrel-pharmaceuticals-llc/736c7b2a-37b0-4e12-a24c-937b15b480ed
Source feed: FDA_Inspections

> FDA Inspection 1300468 for Safrel Pharmaceuticals LLC on January 30, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300468
- Company Name: Safrel Pharmaceuticals LLC
- Inspection Date: 2026-01-30
- Project Area: Food Composition, Standards, Labeling, and Economics
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1300468 - 2026-01-30](https://www.keypedia.com/records/fda_inspections/safrel-pharmaceuticals-llc/b8d841fd-8b95-4168-ae4f-a4520cc73dbd)
- [FDA Inspection 1300468 - 2026-01-30](https://www.keypedia.com/records/fda_inspections/safrel-pharmaceuticals-llc/709ac3ac-84c3-4049-802e-5ab41a57f620)

Company: https://www.keypedia.com/companies/safrel-pharmaceuticals-llc/3656e327-293c-4e9f-86df-6fd8e00ce1f1

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248